EvoEndo Selected to Exhibit its Single-Use Endoscopy System at Vizient Innovative Technology Exchange
DENVER, CO—EvoEndo®, Inc. (“EvoEndo”), a medical device company developing systems for Unsedated Transnasal Endoscopy (TNE), has been selected to exhibit the EvoEndo® Single-Use Endoscopy System at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven health care performance improvement company, will hold the Exchange on October 17 in Dallas.
The annual Innovative Technology Exchange offers selected suppliers the unique opportunity to demonstrate their technologies to supply chain and clinical leaders from Vizient’s member hospitals and subject matter experts who serve on their supply councils. Each technology will showcase how it improves clinical outcomes, enhances safety or drives incremental improvements to health care delivery or business models.
The EvoEndo Single-Use Endoscopy System allows patients five and older to undergo a transnasal EGD exam without anesthesia or sedation. EvoEndo’s ultra-slim gastroscope, virtual reality patient distraction, and comprehensive training program are specifically designed to help physicians and hospitals establish a TNE program within their own practice, providing an unsedated alternative to upper endoscopy for patients and their families.
“We are excited to showcase the EvoEndo® Single-Use Endoscopy System at this year’s Vizient Innovative Technology Exchange,” said Heather Underwood, Chief Executive Officer at EvoEndo. “The critical need to reduce the use of general anesthesia and sedation during endoscopic procedures was the inspiration and driving force behind the innovation of our system. Alongside other health care suppliers and innovators alike, we are eager for the opportunity to demonstrate how our system’s unique features enable clinical benefits for both patients and providers.”
“Suppliers come to the Exchange hoping to be awarded an Innovative Technology contract, which signals health care providers of their product’s unique qualities,” said Kelly Flaharty, senior director of contract services, Vizient. “We are pleased to include this technology in the group selected to participate.”
The annual Innovative Technology Exchange is part of Vizient’s Innovative Technology Program that includes product review of supplier-submitted technologies by member-led councils and task forces. Since 2003, Vizient has reviewed over 1,600 product submissions as part of its Innovative Technology Program.
EvoEndo, Inc. is a medical device company developing systems that enable unsedated endoscopic procedures through a combination of sterile single-use, flexible endoscopes and VR-based patient distraction. EvoEndo’s single-use ultra-slim endoscope technology is designed to facilitate unsedated transnasal upper endoscopies without the use of general anesthesia or sedation for both adults and pediatric patients ages five and older. To learn more, please visit evoendo.com.